Building Blocks

<p>N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide is a nonsteroidal compound that inhibits the activity of certain kinases involved in the inflammatory response. It has been shown to reduce inflammation and modulate immune responses, as well as regulate immune cells. N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide also has a regulatory effect on nitrogen metabolism and participates in the regulation of cell proliferation. This drug may be useful for treating diseases related to immunology, such as chronic obstructive pulmonary disease or arthritis.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>DFPM is an organic compound with the chemical formula C8H6F3N. It has been shown to have a weak effect on the production of cytosolic Ca2+ in plant cells. DFPM also binds to and inhibits the activity of an unknown protein that is involved in regulating Ca2+ levels. The binding site for DFPM is located at the active site of this protein, which is located in the cytosol. The binding site for DFPM has not been identified.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-[(2-Nitrophenyl)sulfonyl]piperazine (1-NPSP) is a novel acetylcholine receptor antagonist that can be synthesized. It has been shown to have an addictive potential and has been used in animal models for this purpose. 1-NPSP also inhibits the synthesis of amines, and has been shown to have cytotoxic effects on certain types of cancer cells.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Flt-3 inhibitors are a class of drugs that inhibit the tyrosine kinase activity of the Flt-3 receptor. This receptor is overexpressed in many cancers and its inhibition has been shown to induce apoptosis in cancer cells. The anti-leukemic activity of flt-3 inhibitors has been demonstrated in animal models and clinical studies have shown potent inhibitory activity against leukemia cells. In addition, this drug has been shown to be effective against epithelial cancers such as breast cancer and colon cancer. Flt-3 inhibitors have also been shown to inhibit tumor growth in animal models by blocking the production of vascular endothelial growth factor (VEGF).</p>

<p>Versatile small molecule scaffold</p>